ALS-002158
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ALS-002158, covering 2017-10-31 to 2017-10-31. Get the full timeline:
Most recent: Clinical Trial Update: First in Human Study of ALS-002158; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1 [Phase 1]